Controlled Study of Chain Blanket for Insomnia
NCT03546036 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 119
Last updated 2018-07-17
Summary
The aim of the study is to compare an intervention with a weighted metal chain blanket of 8 kg with a control plastic chain blanket of 1,5 kg for patients with Major depressive disorder, bipolar disorder, Generalized Anxiety Disorder (GAD) and/or attention deficit hyperactivity disorder (ADHD) and co-occurring insomnia. Patients are evaluated by a rater blind to treatment allocation with Insomnia Severity Index (ISI), Fatigue Symptom Inventory (FSI), Hospital Anxiety and Depression Scale (HAD) and actigraphy before, during and at primary end-point after 4 weeks use of the blanket.
Conditions
Interventions
- DEVICE
-
Weighted metal chain blanket
Use of a weighted metal chain blanket of 8 kg
- DEVICE
-
Control plastic chain blanket
A blanket with light plastic chains
Sponsors & Collaborators
-
Region Stockholm
collaborator OTHER_GOV - lead OTHER
Principal Investigators
-
Mats Adler, M.D. Ph.D. · Karolinska Institutet
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-04
- Primary Completion
- 2017-07-07
- Completion
- 2018-06-20
Countries
- Sweden
Study Locations
More Related Trials
-
MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED)
NCT00266344 ·Status: COMPLETED ·Phase: PHASE2
-
An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)
NCT00103818 ·Status: COMPLETED ·Phase: PHASE3
-
Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED)
NCT00094666 ·Status: TERMINATED ·Phase: PHASE3
-
An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia
NCT03338764 ·Status: WITHDRAWN ·Phase: PHASE3
-
Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED)
NCT00266357 ·Status: TERMINATED ·Phase: PHASE2
-
Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED)
NCT00095043 ·Status: COMPLETED ·Phase: PHASE3
-
SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.
NCT03331042 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep
NCT03679884 ·Status: COMPLETED ·Phase: PHASE3
-
Melatonin 3mg and 5mg Compared to Cognitive Behavioral Therapy for Insomnia (CBT-I) in the Treatment of Insomnia
NCT02798367 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)
NCT00095069 ·Status: COMPLETED ·Phase: PHASE3
-
Improving Sleep and Psychological Functioning in People With Depression and Insomnia
NCT00247624 ·Status: COMPLETED ·Phase: PHASE4
-
Use of Blinded Tapering for Hypnotic Discontinuation
NCT04050176 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety and Efficacy of Ramelteon and Doxepin in Subjects With Chronic Insomnia
NCT00755495 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Gaboxadol in Primary Insomnia
NCT00209846 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine for Primary Insomnia Patients : A Randomized Controlled Trial
NCT00328822 ·Status: COMPLETED ·Phase: NA
-
A Study of Gaboxadol in Primary Insomnia
NCT00209924 ·Status: COMPLETED ·Phase: PHASE3
-
The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy
NCT02669082 ·Status: COMPLETED ·Phase: PHASE4
-
Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.
NCT00247390 ·Status: COMPLETED ·Phase: PHASE3
-
Combined Behavioral/Pharmacological Therapy for Insomnia
NCT00044629 ·Status: COMPLETED ·Phase: PHASE2
-
Insomnia in Older Adults: Impact of Personalized, Diet-Induced Alterations in the Microbiota
NCT03085446 ·Status: COMPLETED ·Phase: NA
-
The Study of Combination Use of Melatonin Receptor Agonist for Dose Reduction or Interruptions of Benzodiazepine (BZD) and Non-BZD Hypnotics on Chronic Insomnia
NCT03461042 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Study of a Combination Drug Product for Treatment of Short-term Insomnia
NCT02671760 ·Status: COMPLETED ·Phase: PHASE2
-
Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder
NCT00552760 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Ramelteon in Adults With Chronic Insomnia
NCT00237497 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder
NCT03375203 ·Status: COMPLETED ·Phase: PHASE2